STRIVE Post-Market Registry Study

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 9, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

April 30, 2028

Conditions
Emphysema
Interventions
DEVICE

Spiration Valve System (SVS)

Spiration Valves are one-way endobronchial valves indicated for adult patients with shortness of breath and hyperinflation associated with severe emphysema in regions of the lung that have evidence of low collateral ventilation. The Spiration Valve is loaded in the deployment catheter, then passed through the channel of a flexible bronchoscope and deployed at the intended target location. The SVS device is designed to relieve the symptoms of shortness of breath and hyperinflation associated with severe emphysema without surgery.

Trial Locations (13)

17033

RECRUITING

Penn State Milton S. Hershey Medical Center, Hershey

19140

RECRUITING

Temple University, Philadelphia

27710

RECRUITING

Duke University Medical Center, Durham

29621

RECRUITING

AnMed Health, Anderson

39501

RECRUITING

Memorial Hospital at Gulfport, Gulfport

60611

RECRUITING

Northwestern University, Division of Pulmonary and Critical Care Medicine, Chicago

60637

RECRUITING

University of Chicago, Chicago

71130

RECRUITING

LSU Health Shreveport, Shreveport

75204

RECRUITING

Baylor Scott & White Research Institute, Dallas

75390

RECRUITING

University of Texas Southwestern, Dallas

85013

RECRUITING

Dignity Health St. Joseph's Hospital and Medical Center, Phoenix

94040

RECRUITING

El Camino, Taft Center for Clinical Research, Mountain View

02215

RECRUITING

Beth Israel Decaconess, Boston

All Listed Sponsors
lead

Olympus Corporation of the Americas

INDUSTRY

NCT04302272 - STRIVE Post-Market Registry Study | Biotech Hunter | Biotech Hunter